Northern Trust Corp Avidity Biosciences, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 760,072 shares of RNA stock, worth $32.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

760,072

Previous 671,328 13.22%

Holding current value

$32.2 Million

Previous $17.1 Million 81.23%

% of portfolio

0.01%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$22.73 - $40.85 $2.02 Million - $3.63 Million	88,744 Added 13.22%	760,072 $31 Million
Q1 2024 May 14, 2024	BUY	$9.16 - $25.52 $77,493 - $215,899	8,460 Added 1.28%	671,328 $17.1 Million
Q4 2023 Feb 13, 2024	BUY	$4.87 - $9.37 $109,691 - $211,049	22,524 Added 3.52%	662,868 $6 Million
Q3 2023 Nov 13, 2023	SELL	$6.3 - $11.35 $70,282 - $126,620	-11,156 Reduced 1.71%	640,344 $4.09 Million
Q2 2023 Aug 11, 2023	BUY	$10.62 - $17.34 $531,987 - $868,612	50,093 Added 8.33%	651,500 $7.23 Million
Q1 2023 May 15, 2023	BUY	$15.35 - $25.65 $1.13 Million - $1.89 Million	73,552 Added 13.93%	601,407 $9.23 Million
Q4 2022 Feb 13, 2023	BUY	$10.06 - $22.66 $472,286 - $1.06 Million	46,947 Added 9.76%	527,855 $11.7 Million
Q3 2022 Nov 14, 2022	BUY	$15.46 - $23.43 $370,947 - $562,179	23,994 Added 5.25%	480,908 $7.85 Million
Q2 2022 Aug 12, 2022	BUY	$11.18 - $20.5 $933,753 - $1.71 Million	83,520 Added 22.37%	456,914 $6.64 Million
Q1 2022 May 13, 2022	SELL	$14.2 - $23.78 $83,027 - $139,041	-5,847 Reduced 1.54%	373,394 $6.9 Million
Q4 2021 Feb 08, 2022	BUY	$20.4 - $28.66 $489,824 - $688,155	24,011 Added 6.76%	379,241 $9.01 Million
Q3 2021 Nov 15, 2021	BUY	$18.16 - $25.21 $1.52 Million - $2.12 Million	83,960 Added 30.95%	355,230 $8.75 Million
Q2 2021 Aug 13, 2021	SELL	$19.62 - $29.26 $321,944 - $480,127	-16,409 Reduced 5.7%	271,270 $6.7 Million
Q1 2021 May 12, 2021	BUY	$20.28 - $28.15 $1.94 Million - $2.69 Million	95,456 Added 49.66%	287,679 $6.27 Million
Q4 2020 Feb 11, 2021	SELL	$24.73 - $35.12 $29,774 - $42,284	-1,204 Reduced 0.62%	192,223 $4.91 Million
Q3 2020 Nov 16, 2020	BUY	$23.35 - $35.94 $4.52 Million - $6.95 Million	193,427 New	193,427 $5.45 Million

Others Institutions Holding RNA

# of Institutions

206

Shares Held

95.5M

Call Options Held

171K

Put Options Held

196K

View Full List

About Avidity Biosciences, Inc.

Ticker RNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,127,000
Market Cap $2.21B
Description
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...

More about RNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Avidity Biosciences, Inc. Transaction History